Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 42 of 56
The slide uses a process flow diagram to illustrate the clinical trial strategy for SPY001 and SPY003.
Pitch deck · roadmap · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 diagram 1/1 source-note 1/1 title 1/1
Components 4
primary process source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1